6-day eradication treatment of helicobacter pylori infection in a non- hospital practice;Kurzzeit-eradikation der helicobacter-pylori-infektion uber 6 tage in der kassenarztpraxis

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 5, 1998, Pages 103-108

  Seelis, R E A ^a   Dohmen, W ^b  

^a Gastroenterologische Facharztpraxis   (Germany)

^b Lehrpraxis für Allgemeinmedizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLARITHROMYCIN; LANSOPRAZOLE; PANTOPRAZOLE; TINIDAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; DRUG EFFICACY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; STOMACH EROSION;

EID: 0032579223     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023912     Document Type: Article

References (41)

1. Adamek, R. J., C. Szymanski, B. Pfaffenbach, W. Opferkuch, D. Ricken, M. Wegener: Kurzeit-Tripel-Therapie mit Pantoprazol, Clarithromycin und Metronidazol zur Heilung der Helicobacter-pylori-Infektion. Dtsch. med. Wschr. 120 (1995), 358-360.
2. Asaka, M., M. Kato, M. Kudo, M. Katagiri, K. Nishikawa, H. Koshiyama, K. Takeda, J.-J. Yoshida, D. Y. Graham: Atrophic changes of gastric mucosa caused by Helicobacter pylori infection rather than aging. Studies in asymptomatic japanese adults. Helicobacter 1 (1996), 52-56.
3. Bayerdörffer, E., M. M. Ritter, R. Hatz, M. Stolte: Menetrier's disease and Helicobacter pylori. New Engl. J. Med. 329 (1993), 60-63.
4. Bayerdörffer, E., S. Miehlke, G. A. Mannes: Doubleblind trial of omeprazol and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcer. Gastroenterology 108 (1995), 1412-1417.
5. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, G. Alampi, P. Simoni, A. Roda, E. Roda: Short-term, low-dose triple therapy for eradication of Helicobacter pylori. Europ. J. Gastroenterol. Hepatol. 6 (1994), 773-777.
6. Bokemeyer, B.: Kombinierte Therapie mit Azithromycin und Omeprazol zur Eradikation von Helicobacter pylori. Dtsch. med. Wschr. 120 (1995), 1339.
7. Breuer, T., T. Sudhop, H. M. Malaty, K. Goodmann, D. Y. Graham, P. Malfertheiner: Do physicans from different countries treat H. pylori positive ulcer disease differently. A comparison between America and Germany. Gut 39 (1996), Suppl. 3, A 189.
8. Caspary, W. F., R. Arnold, E. Bayerdörffer, R. Behrens, B. Birkner, B. Braden, W. Domschke, J. Labenz, S. Koletzko, P. Malfertheiner, H. Menge, W. Rösch, W. Schepp, M. Strauch, M. Stolte: Diagnostik und Therapie der Helicobacter pylori-Infektion. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Z. Gastroenterol. 34 (1996), 392-401.
9. Chiba, N., B. V. Rao, J. W. Rademaker, R. H. Hunt: Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Amer. J. Gastroenterol. 87 (1992), 1716-1727.
10. Correa, P.: Human gastric carcinogenesis. A multistep and multifactorial process. Cancer Res. 52 (1992), 1635-1640.
11. Crouch, A. A., W. K. Seow, L. M. Whitmann, J. H. Thong: Sensitivity in vitro of Gardia intestinalis to dyadic combinations of azithromycin, doxycyline, mefloquine, tinidazole and flurozolidone. Trans. Roy. Soc. Trop. Med. Hyg. 84 (1990), 246-248.
12. De Boer, W. A., G. N. Y. Tytgat: The best therapy for Helicobacter pylori infection. Should efficacy or side-effect-profile determine our choice? Scand. J. Gastroenterol. 30 (1995), 401-407.
13. De Boer, W. A., W. M. M. Driessen, H. V. P. J. Potters, G. N. Y. Tytgat: Randomized study comparing 1 with 2 weeks quadruple therapy for eradicating Helicobacter pylori. Amer. J. Gastroenterol. 89 (1994), 1993-1997.
14. Deltenre, M., C. Jonas, J. Otero, A. Cozzol, P. Denis, A. Burrette, E. De Koster: Strategies for Helicobacter pylori eradication in 1995. A review of international and belgian experience. J. Physiol. Pharmacol. 47 (1996), 59-69.
15. Dohmen, W., R. Seelis: Helicobacter-Therapie in der Praxis. Z. Allg. Med. 72 (1996), 1431-1433.
16. Domschke, W., A. Dettmer, T. Fenner, P. Hesse, G. Holtmann, N. van Husen, S. E. Miederer, K. U. Schentke, E. Schütz, L. Stölzle, D. Wöstenberg: Helicobacter pylori und peptisches Ulkus. Therapeutische Indikation und Empfehlung 1995 einer Expertenrunde in Münster. Z. Gastroenterol. 33 (1995), 598-601.
17. Eisenbach, T. H., B. Weidmann: Helicobacter pylori-Eradikation mit Lansoprazol und Amoxycillin. Kassenarzt 42 (1995), 56-58.
18. Goddard, A., R. Logan: One week low dose triple therapy. New Standards for Helicobacter pylori treatment. Europ. J. Gastroenterol. Hepatol. 7 (1995), 1-3.
19. Graham, D. Y.: Treatment of peptic ulcers caused by Helicobacter pylori. New Engl. J. Med. 328 (1993), 349-350.
20. Graham, D. Y., G. M. Lew, H. M. Malaty, D. G. Evans, D. Y. Evans, P. D. Klein: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102 (1992), 493-496.
21. Harrison, J. D., J. A. Jones, D. L. Morris: Azithromycin levels in plasma and gastric tissue, juice and mucus. Europ. J. Clin. Microbiol. Infect. Dis. 10 (1991), 862-864.
22. Holocombe, C., B. A. Omotora, J. Eldridge, D. M. Jones: H. pylori, the most common bacterial infection in Africa. A random serological study. Amer. J. Gastroenterol. 87 (1992), 28-30.
23. Hunt, R. H., P. Malfertheiner, N. D. Yeomanns, C. J. Hawkey, C. W. Howden: Critical issue in the pathophysiology and management of peptic ulcer disease. Europ. J. Gastroenterol. Hepatol. 7 (1995), 685-699.
24. IARC: International Agency for Research in Cancer. Schistosomas, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks. Hum. 61 (1994).
25. Labenz, J., G. Börsch: Towards an optimal treatment of Helicobacter pylori-positive peptic ulcers. Amer. J. Gastroenterol. 90 (1995), 692-694.
26. Labenz, J., B. Tillenburg, U. Peitz, H. Köhl, T. Becker, M. Stolte, G. Börsch: Ulcusheilung durch Helicobacter-pylori-Eradikation. Genügt eine Woche Therapie? Dtsch. med. Wschr. 121 (1996), 3-8.
27. Labenz, J., M. Stolte, C. Domian, J. Bertrams, C. Börsch: High-dose omeprazol plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. Digestion 56 (1995), 14-20.
28. Labenz, J., G. Börsch: Aktuelle Therapie der Helicobacter-pylori-Infektion. In Malfertheiner P. (Hrsg.): Helicobacter pylori. Von der Grundlage zur Therapie (Thieme: Stuttgart 1996), 149-163.
29. Lind, T., S. J. O. Veldhuyzen van Zanten, P. Unge, R. C. Spiller, E. Bayerdörffer, C. O. Morain, M. Wrangstadh, J. P. Idström: The MACH-1-Study. Optimal one-week treatment for H. pylori defined? Gut 37 (Suppl. 1) (1995), A 15.
30. Logan, R. P. H.: Helicobacter pylori and gastric cancer. Lancet 344 (1994), 1078-1079.
31. Logan, R. P. H., M. M. Walker, J. J. Misiewicz, P. A. Gummett, Q.N. Karim, J. H. Baron: Changes in the intra gastric distribution of Helicobacter pylori during treatment with omeprazol. Gut 36 (1995), 12-16.
32. Marchegiani, A., F. Di Capua: Combined omeprazol/azithromycin therapy regimen for eradication of Helicobacter pylori. Acta gastroenterol. Belg. Suppl. 56 (1993), 141.
33. Mégraud, F.: H. pylori resistence to antibiotics. In Hunt, R. H., C. N. Y. Tytgat (Ed.): Basic mechanismus to clinical cure 1996 (Kluwer: Dordrecht 1996), 348-356.
34. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. J. Amer. Med. Ass. 1 (1994), 65-69.
35. Opferbuch, W., S. Suerbaum: Diagnostik und Therapie der Helicobacter pylori-Infektion. Clarithromycin-Dosis erhöhen. Dtsch. Ärztebl. 93 (1996), 3355-3356.
36. Rosario, M., R. Omar, J. A. Santos, I. Alves, A. Sales-Luis: Efficacy of an anti Helicobacter pylori triple therapy regimen in a routine clinical practice setting. Helicobacter pylori (Basic mechanismus to clinical cure Ottawa: 1996), abstract 65.
37. Stadelmann, O.: Helicobacter pylori. Indikation und Praxis der Therapie. Dtsch. Ärztebl. 39 (1995), 59-61.
38. Tobai, G., D. Hüppe, B. Schenck, K. G. Furche: Eradikation von Helicobacter pylori bei Ulcera ventriculi oder duodeni. Münch. med. Wschr. 138 (1996), 277-281.
39. Tytgat, G. N. Y.: Review article. Treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment. Pharmacol. Ther. 8 (1994), 359-368.
40. Van der Hulst, R. W. M., J. J. K. Keller, E. A. J. Rauws, G. N. Y. Tytgat: Treatment of Helicobacter pylori-Infection. A review of the world literature. Helicobacter 1 (1996), 6-19.
41. Wotherspoon, A. C., C. Oritz Hidalgo, M. R. Falzon, P. G. Isaacson: Helicobacter pylori-associated gastritis and primary B cell gastric lymphoma. Lancet 338 (1991), 1175-1176.